CJEU rejects Viridis TM plea over MS drug

03-07-2019

CJEU rejects Viridis TM plea over MS drug

Castleski / Shutterstock.com

The Court of Justice of the European Union (CJEU) has rejected a trademark appeal submitted by Virgin Islands-headquartered Viridis Pharmaceutical.


Court of Justice of the European Union, trademark opposition, Multiple Sclerosis, clinical trials, trademark, Viridis Pharmaceutical, Hecht-Pharma, CJEU

LSIPR